Company Profile

SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

02/03	SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion	MT
07/11	SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan	MT

02/03	SciBase Wins US FDA Nod for Skin Cancer Detection Device Label Expansion	MT
07/11	SciBase, Castle Biosciences Expand License Deal, Secures SEK20 Million Loan	MT
07/11	SciBase Plans Warrant Buyback; Mulls SEK83 Million Rights Issue	MT
23/09/25	SciBase Lands Point-of-care Platform Order Under Clinical Study Partnership	MT
10/09/25	SciBase's Shareholders Boost Stakes	MT
08/07/25	SciBase Wins New Order for Skin Cancer Diagnostic Platform in US	MT
24/06/25	SciBase to Raise SEK11 Million in Second Directed Share Issue	MT
17/06/25	SciBase Plans Up to SEK30 Million Equity Raise	MT
17/06/25	SciBase Signs Dermatological Diagnostic Tests Collaboration With Castle Biosciences	MT
05/06/25	Sweden's SciBase Receives First Italian Order	MT
31/01/25	Sweden's SciBase Onboards US Dermatology Practices	MT
13/11/24	Inderes raises target price for Scibase to SEK 0.45 (0.40), reiterates reduce - BN	FW
12/11/24	SciBase to Raise SEK82 Million via Directed, Rights Issue if UNits	MT

29/05	SciBase announces that the board of directors has resolved on the record date for the reverse share split	AQ
28/05	Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study	AQ
19/05	Bulletin from the annual general meeting in SciBase Holding AB (publ)	AQ
18/05	Scibase : Presentation proposed board of directors	PU
18/05	SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes	AQ

Manager	Title	Age	Since
Pia Renaudin CEO	Chief Executive Officer	59	01/10/2023
Michael Colérus DFI	Director of Finance/CFO	64	01/01/2014
Jvalini Dwarkasing CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Diana Ferro BRD	Director/Board Member	60	16/05/2017
Jesper Høiland CHM	Chairman	65	13/06/2024
Anna Maria Albertina Eriksrud BRD	Director/Board Member	68	-

Scibase AB Stock Swiss Exchange

Stocks

SE0007045414

Advanced Medical Equipment & Technology

Latest news : Scibase AB

Analysts' recommendations: Scibase AB

Press Releases: Scibase AB

Managers and Directors: Scibase AB

Medical Diagnostic & Testing Equipment

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SARTORIUS AG	+1.10%	+2.23%	+5.58%	-26.21%	16.36B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+5.89%	+23.51%	+46.13%	+99.78%	1.78B
QUIDELORTHO CORPORATION	+0.39%	+32.34%	-39.55%	-78.20%	1.24B
ECKERT & ZIEGLER SE	0.00%	+3.99%	-28.36%	+38.25%	1.14B
CONTEC MEDICAL SYSTEMS CO.,LTD	+1.31%	+4.95%	-25.50%	-53.00%	640M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+0.21%	+3.42%	-36.59%	-56.57%	582M
VAREX IMAGING CORPORATION	-0.66%	+3.11%	+20.57%	-54.11%	447M
REVENIO GROUP OYJ	+0.96%	+1.12%	-54.35%	-59.12%	382M
CELLAVISION AB	+0.55%	+8.86%	-18.56%	-18.65%	362M
Average	+1.10%	+7.61%	-14.51%	-23.09%	2.55B
Weighted average by Cap.	+1.34%	+4.51%	+1.58%	-18.52%

End-of-day quote Swiss Exchange Other stock markets
- ^SEK	-